| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Faculty of Pharmacy, The University of Sydney, Sydney, New South Wales, Australia
* To whom correspondence should be addressed. E-mail: basilr{at}pharm.usyd.edu.au.
Intracellular traffic of human P-glycoprotein (P-gp), a membrane transporter responsible for multidrug resistance in cancer chemotherapy, was investigated using a P-gp and enhanced green fluorescent fusion protein (P-gp-EGFP) in human breast cancer MCF-7 cells. The stably expressed P-gp-EGFP from a clonal cell population was functional as a drug efflux pump, as demonstrated by the inhibition of daunorubicin accumulation and the conferring of resistance of the cells to colchicine and daunorubicin. Co-localization experiments demonstrated that a small fraction of the total P-gp-EGFP expressed was localized intracellularly and was present in early endosome and lysosome compartments. P-gp-EGFP traffic was shown to occur via early endosome transport to the plasma membrane. Subsequent movement of P-gp-EGFP away from the plasma membrane occurred by endocytosis to the early endosome and lysosome. The component of the cytoskeleton responsible for P-gp-EGFP traffic was demonstrated to be actin rather than microtubule. In functional studies it was shown that in parallel with the interruption of the traffic of P-gp-EGFP, cellular accumulation of the P-gp substrate daunorubicin was increased after cells were treated with actin inhibitors, and cell proliferation was inhibited to a greater extent than in the presence of daunorubicin alone. The actin dependence of P-gp traffic and the parallel changes in cytotoxic drug accumulation demonstrated in this study delineates the pathways of P-gp traffic and may provide a new approach to overcoming multidrug resistance in cancer chemotherapy.
This article has been cited by other articles:
|
|
 |
|
  I. Bottova, A. B. Hehl, S. Stefanic, G. Fabrias, J. Casas, E. Schraner, J. Pieters, and S. Sonda Host Cell P-glycoprotein Is Essential for Cholesterol Uptake and Replication of Toxoplasma gondii J. Biol. Chem., June 26, 2009; 284(26): 17438 - 17448. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ye, D. P. MacEachran, J. W. Hamilton, G. A. O'Toole, and B. A. Stanton Chemotoxicity of doxorubicin and surface expression of P-glycoprotein (MDR1) is regulated by the Pseudomonas aeruginosa toxin Cif Am J Physiol Cell Physiol, September 1, 2008; 295(3): C807 - C818. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Siccardi, K. L. Mumy, D. M. Wall, J. D. Bien, and B. A. McCormick Salmonella enterica serovar Typhimurium modulates P-glycoprotein in the intestinal epithelium Am J Physiol Gastrointest Liver Physiol, June 1, 2008; 294(6): G1392 - G1400. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Randhawa, N. A. Farasati, and Y. Huang BK Virus Replication In Vitro: Limited Effect of Drugs Interfering with Viral Uptake and Intracellular Transport Antimicrob. Agents Chemother., December 1, 2007; 51(12): 4492 - 4494. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |
